Tags

Pediatric brain cancer

Kazia Therapeutics doses first patient in paediatric brain cancer trial

Kazia Therapeutics doses first patient in paediatric brain cancer trial

September 11, 2026 | 14:54
Kazia Therapeutics initiated dosing in its PNOC035 clinical study evaluating drug candidate paxalisib alongside gemcitabine for children and young adults with recurrent AT/RT brain cancer.

Latest News

Vietnam, AFD strengthen development cooperation for new phase

Vietnam, AFD strengthen development cooperation for new phase

Vietnam and France seek to deepen economic and financial cooperation

Vietnam and France seek to deepen economic and financial cooperation

Vietnam and France exchange financing agreements for water management project in Dien Bien

Vietnam and France exchange financing agreements for water management project in Dien Bien

Daesang expands into biopharmaceuticals using 70 years of fermentation tech

Daesang expands into biopharmaceuticals using 70 years of fermentation tech

Vietnam Investment Review under the Ministry of Finance

Editor-in-Chief: Pham Van Hoanh

Deputy Editors-in-Chief: Le Trong Minh, Ngo Chi Tung, Nguyen Van Hong

Managing Editor: Nguyen Chi Mai

Advertisement  | Contact us

Based on MasterCMS Ultimate Edition 2026 v2.9
Corporate CEO Talk Biz Link PR Newswire Media OutReach Newswire
Investing M&A Outbound Investment Investing in Haiphong
Your Consultant KPMG PwC Indochine Counsel Vilasia Ansarada
Green Growth Energy Efficiency Rethinking Plastics BASF
Property Green Buildings Industrial Properties
Money Insurance Smart Payment Trends Stock Monitor
Infographics
Timeout Travel Hotels & Restaurants The Insider Entertainment Lifestyle
Sports
Photos
Society Swing for the Kids CSR
World News
virs-publications-vir
timeout-vn
ptbv2020